ProMIS Neurosciences PMN
NASDAQ PMN
$9.40 +0.02 (+0.21%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProMIS Neurosciences (PMN) Capital Expenditures (2021 - 2022)

Updated

ProMIS Neurosciences (PMN) recorded Capital Expenditures of -$43.00 in Q4 2022, compared with $4,857 a year earlier.

Analysis

ProMIS Neurosciences (PMN) Capital Expenditures (2021 - 2022) Analysis & Trends

For FY2022, ProMIS Neurosciences reported Capital Expenditures of $1,981, down 67.2% from FY2021.

  • Across earlier years, Capital Expenditures came in at $6,044 in FY2021.
  • Per Business Quant, the preceding three quarters came in at -$24.00 (Q3 2022), -$9.00 (Q2 2022) and $2,057 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.32 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 322.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -321.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -763.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 140.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 533.00 Mn
10 ProMIS Neurosciences 84.30 Mn -54.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -43.00
Sep 30, 2022 -24.00
Jun 30, 2022 -9.00
Mar 31, 2022 2,057.00
Dec 31, 2021 4,857.00
API Access

ProMIS Neurosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PMN&period=max&api_key=YOUR_API_KEY